Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for relapsed/refractory multiple myeloma following Ph3 trials
Antibody-drug conjugate, cancer, multiple myeloma, BCMA target, combination therapy - Read more

Merck & Co., Sarah Cannon Research Institute collaborate to expand community-based oncology trial access using Accelero model
Research collaboration, oncology, clinical trials, drug development, community oncology - Read more

Tolerance Bio licenses NeoImmuneTech's IL-7 fusion protein for thymus indications, up to $260M milestones
Licensing deal, autoimmune, fusion protein, milestone payments, royalties, equity investment - Read more

BeOne Medicines, BeOne Care Foundation, The Max Foundation renew CLL access partnership through 2028, $1M grant
Patient access, oncology, small molecule, commercialization - Read more

Kedrion Biopharma, Grifols extend U.S. agreement to maintain patient access to GAMMAKED IVIG therapy
Licensing deal, rare disease, autoimmune, neurological, biologics, commercialization - Read more

Genprex partners with undisclosed CDMO to scale up AAV-based diabetes gene therapy manufacturing
Manufacturing agreement, gene therapy, diabetes, AAV vector, CDMO - Read more

Ready to supercharge your marketing AND sales workflows into biopharma?

You won’t want to miss this webinar, where Kimo (Hapatune) and Anis (Science 2 Sales) get into the nitty-gritty of both:

• Audience segmentation (how tailored marketing content can more effectively engage a focused bioprocess customer segment) and
• Cold calling (the technical underpinning and strategies + mindset to win at it)

Join us August 26th - register for free here!

Enveda's (ENV-308) Lac-Phe mimic clears Ph1 safety trial, advancing to Ph2 for obesity treatment
Small molecule, metabolic, obesity, GLP-1, Lac-Phe, appetite suppression - Read more

Merck & Co., Moderna's intismeran autogene (mRNA-4157) plus Keytruda (pembrolizumab) reduces recurrence risk in Ph3 melanoma trial
Vaccine, cancer, mRNA vaccine, melanoma, pembrolizumab, combination therapy - Read more

CSL shares surge 17% on immunoglobulin demand recovery and stronger-than-expected $15.8B revenue
Plasma-derived therapy, rare disease, financial, operational - Read more

NeuroThera Labs raises C$5.4M ($3.9M) private placement, advancing CNS disorder treatments
Clinical-stage, neurological, central nervous system, small molecule - Read more

Abcuro raises $66M Series D, advancing first-in-class therapy for inclusion body myositis
Autoimmune, antibody, inclusion body myositis, clinical-stage, rare disease - Read more

SK Pharmteco completes two API manufacturing facilities in Swords, Ireland, boosting HPAPI and small-molecule capacity
Small molecule, ADC, manufacturing, operational - Read more

Teva Pharmaceuticals scores partial appellate win, sending CMS drug price negotiation challenge back to lower court
Small molecule, neurological, regulatory, competitive - Read more

SK Biopharmaceuticals settles with MSN Laboratories over Xcopri generics, extending market exclusivity beyond 2032
Small molecule, neurology, patent settlement, market exclusivity - Read more

PitchBook predicts rebounding biotech VC funding to drive CDMO demand growth within two to four quarters
CDMO, cell and gene therapy, financial, strategic - Read more

GenBio AI launches AIDO Cell, Nobel laureate-backed virtual cell model to accelerate drug discovery
AI drug discovery, oncology, operational, competitive - Read more

Trump nominates White House aide Heidi Overton as new FDA commissioner
FDA leadership, drug review process, regulatory, operational - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

Kolon TissueGene lays off 37 employees after phase 3 knee osteoarthritis trial failure
Cell therapy, musculoskeletal, operational, cost reduction - Read more

NIH cancels $15M in Alzheimer's and brain health grants at Emory University and University of Pittsburgh
Neurological, Alzheimer's disease, NIH funding, operational - Read more

FDA issues warning letter to Aurobindo's Eugia unit over sterile manufacturing and contamination violations
Small molecule, oncology, operational, manufacturing compliance - Read more

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here